Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
21.63 USD | -0.22 USD | -1.03 % |
---|
Vortag | 21.86 USD | Datum | 07.02.2025 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 346.00% | |
21Shares Stellar ETP | CH1109575535 | 232.70% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares The Sandbox ETP | CH1177361008 | 134.26% | |
21Shares Algorand ETP | CH1146882316 | 125.07% | |
21Shares Sui Staking ETP | CH1360612159 | 39.37% | |
21Shares Immutable ETP | CH1360612142 | -34.85% | |
21Shares Injective Staking ETP | CH1360612134 | -40.06% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Sui Staking ETP | CH1360612159 | 396.35% | |
21Shares Ripple XRP ETP | CH0454664043 | 300.91% | |
21Shares Stellar ETP | CH1109575535 | 232.53% | |
21Shares Aave ETP | CH1135202120 | 153.28% | |
21Shares Stacks Staking ETP | CH1258969042 | 145.10% | |
21Shares Algorand ETP | CH1146882316 | 143.59% | |
21Shares Injective Staking ETP | CH1360612134 | -16.46% | |
21Shares Immutable ETP | CH1360612142 | -33.93% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 367.51% | |
21Shares Stellar ETP | CH1109575535 | 201.24% | |
21Shares Aave ETP | CH1135202120 | 181.92% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 165.65% | |
21Shares Bitcoin Core ETP | CH1199067674 | 115.90% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 784.75% | |
21Shares Ripple XRP ETP | CH0454664043 | 495.43% | |
21Shares Bitcoin Core ETP | CH1199067674 | 328.16% | |
21Shares Bitcoin ETP | CH0454664001 | 317.31% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 281.82% |
Anlagepolitik
So investiert der VanEck Bionic Engineering UCITS ETF A Acc: The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to companies involved in the bionic implants industry including medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.